When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MDCO - The Medicines Company's inclisiran successful in two late-stage studies
The Medicines Company
The Medicines Company (NASDAQ:MDCO) announces positive results from two Phase 3 clinical trials for inclisiran. Both studies met all primary and secondary endpoints with no new safety signals reported. Detailed data will be presented at the American Heart Association Scientific Sessions in Philadelphia in mid-November.
More news on: The Medicines Company, Alnylam Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,